Skip to main content
. 2009 Aug 28;21(3):498–505. doi: 10.1093/annonc/mdp358

Table 4.

Transition between abnormal (≥5 mm) and normal ET after 24 months of randomised treatment

Exemestane
Tamoxifen
Na Normal ET at 24 months, n (%) Abnormal ET (≥5 mm) at 24 months, n (%) N Normal ET at 24 months, n (%) Abnormal ET (≥5 mm) at 24 months, n (%)
Normal ET at baseline 23 19 (83) 4 (17) 23 15 (65) 8 (35)
ET (≥5 mm) at baseline 38 20 (53) 18 (47) 32 6 (19) 26 (81)
a

Baseline TVUS unavailable for one patient.

ET, endometrial thickness; TVUS, transvaginal ultrasound.